Medical and Surgical Management of Colorectal Cancer Patients Presenting with Haemostatic Disorders

  • Valerio Celentano
Part of the Hot Topics in Acute Care Surgery and Trauma book series (HTACST)


Maintaining haemostasis during surgery is essential to preserve physiologic functions for the patient, provide the surgeon with the ability to see the operative field and promote successful wound management and patient outcomes. In addition, effective surgical haemostasis also results in fewer blood transfusions, decreased operating time and reduced morbidity and mortality.

The normal coagulation pathway represents a balance between the procoagulant pathway that is responsible for clot formation and the mechanisms that inhibit the same beyond the injury site. Imbalance of the coagulation system may occur in the perioperative period or during critical illness, which may be secondary to numerous factors leading to a tendency of either thrombosis or bleeding. A multidisciplinary approach is essential, and the surgical team must closely liaise with the haematology and anaesthetic team.

This chapter describes the pathophysiology of the haemostasis and the most common disorders encountered in clinical practice in emergency surgery.


Colorectal cancer Emergency surgery Haemostatic disorders Bleeding disorders 


  1. 1.
    Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013;93(1):327–58.CrossRefGoogle Scholar
  2. 2.
    Tubbs RS. Surgery is simple-it requires only anatomy and hemostasis. Clin Anat. 2015;28(7):821.CrossRefGoogle Scholar
  3. 3.
    Bombeli T, Spahn DR. Updates in perioperative coagulation: physiology and management of thromboembolism and haemorrhage. Br J Anaesth. 2004;93:275–87.CrossRefGoogle Scholar
  4. 4.
    Heemskerk JW, Bevers EM, Lindhout T. Platelet activation and blood coagulation. Thromb Haemost. 2002;88:186–93.CrossRefGoogle Scholar
  5. 5.
    Monroe DM III, Hoffman M, Roberts HR. Molecular biology and biochemistry of the coagulation factors and pathways of hemostasis. In:Williams hematology. 8th ed. New York, NY: McGraw-Hill Professional Publishing; 2010. p. 614–6.Google Scholar
  6. 6.
    Clemetson KJ. Platelets and primary haemostasis. Thromb Res. 2012;129(3):220–4.CrossRefGoogle Scholar
  7. 7.
    Hvas AM. Platelet function in thrombosis and hemostasis. Semin Thromb Hemost. 2016;42(3):183–4.CrossRefGoogle Scholar
  8. 8.
    Johari V, Loke C. Brief overview of the coagulation cascade. Dis Mon. 2012;58(8):421–3.CrossRefGoogle Scholar
  9. 9.
    Chapin JC, Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev. 2015;29(1):17–24.CrossRefGoogle Scholar
  10. 10.
    Ranucci M. Detection of inherited and acquired hemostatic disorders in surgical patients. Can J Anaesth. 2016;63(9):1003–6.CrossRefGoogle Scholar
  11. 11.
    Mensah PK, Gooding R. Surgery in patients with inherited bleeding disorders. Anaesthesia. 2015 Jan;70(Suppl 1):112–20, e39–40.CrossRefGoogle Scholar
  12. 12.
    Escobar MA, Maahs J, Hellman E, et al. Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres. Haemophilia. 2012;18:971–81.CrossRefGoogle Scholar
  13. 13.
    Zulfikar B, Koc B, Ak G, Dikici F, Karaman İ, Atalar AC, Bezgal F. Surgery in patients with von Willebrand disease. Blood Coagul Fibrinolysis. 2016;27(7):812–6.CrossRefGoogle Scholar
  14. 14.
    Bonhomme F, Ajzenberg N, Schved JF, Molliex S, Samama CM, French Anaesthetic and Intensive Care Committee on Evaluation of Routine Preoperative Testing; French Society of Anaesthesia and Intensive Care. Pre-interventional haemostatic assessment: guidelines from the French Society of Anaesthesia and Intensive Care. Eur J Anaesthesiol. 2013;30(4):142–62.CrossRefGoogle Scholar
  15. 15.
    Kruse-Jarres R, Singleton TC, Leissinger CA. Identification and basic management of bleeding disorders in adults. J Am Board Fam Med. 2014;27(4):549–64.CrossRefGoogle Scholar
  16. 16.
    Santagostino E, Fasulo MR. Hemophilia a and hemophilia B: different types of diseases? Semin Thromb Hemost. 2013;39(7):697–701.CrossRefGoogle Scholar
  17. 17.
    Toh CH, Alhamdi Y. Current consideration and management of disseminated intravascular coagulation. Hematology Am Soc Hematol Educ Program. 2013;2013:286–91.CrossRefGoogle Scholar
  18. 18.
    Iqbal CW, Cima RR, Pemberton JH. Bleeding and thromboembolic outcomes for patients on oral anticoagulation undergoing elective colon and rectal abdominal operations. J Gastrointest Surg. 2011;15(11):2016–22.CrossRefGoogle Scholar
  19. 19.
    Tebala GD, Natili A, Gallucci A, Brachini G, Khan AQ, Tebala D, Mingoli A. Emergency treatment of complicated colorectal cancer. Cancer Manag Res. 2018;10:827–38.CrossRefGoogle Scholar
  20. 20.
    Chic Acevedo C, Velasco F, Herrera C. Reversal of rivaroxaban anticoagulation by nonactivated prothrombin complex concentrate in urgent surgery. Futur Cardiol. 2015;11(5):525–9.CrossRefGoogle Scholar
  21. 21.
    Bertina R, Koelman B, Koster T, Rosendaal F, Dirven R, De Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64–7.CrossRefGoogle Scholar
  22. 22.
    Greaves M. Antiphospholipid syndrome. J Clin Pathol. 1997;50:973–4.CrossRefGoogle Scholar
  23. 23.
    White CK, Langholtz J, Burns ZT, Kruse S, Sallee K, Henry DH. Readmission rates due to venous thromboembolism in cancer patients after abdominopelvic surgery, a retrospective chart review. Support Care Cancer. 2015;23(4):993–9.CrossRefGoogle Scholar
  24. 24.
    Krell RW, Scally CP, Wong SL, Abdelsattar ZM, Birkmeyer NJ, Fegan K, Todd J, Henke PK, Campbell DA, Hendren S. Variation in hospital thromboprophylaxis practices for abdominal cancer surgery. Ann Surg Oncol. 2016;23(5):1431–9.CrossRefGoogle Scholar
  25. 25.
    Rasmussen MS, Jørgensen LN, Wille-Jørgensen P. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev. 2009;(1):CD004318.Google Scholar
  26. 26.
    Banerjee AK, Celentano V, Khan J, Longcroft-Wheaton G, Quine A, Bhandari P. Practical gastrointestinal investigation of iron deficiency anaemia. Expert Rev Gastroenterol Hepatol. 2018;12(3):249–56.CrossRefGoogle Scholar
  27. 27.
    Liu L, Liu L, Liang LC, Zhu ZQ, Wan X, Dai HB, Huang Q. Impact of preoperative anemia on perioperative outcomes in patients undergoing elective colorectal surgery. Gastroenterol Res Pract. 2018;2018:2417028.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Maggiori L, Khayat A, Treton X, et al. Laparoscopic approach for inflammatory bowel disease is a real alternative to open surgery: an experience with 574 consecutive patients. Ann Surg. 2014;260(2):305–10.CrossRefGoogle Scholar
  29. 29.
    Sulu B, Aytac E, Stocchi L, Vogel JD, Kiran RP. The minimally invasive approach is associated with reduced perioperative thromboembolic and bleeding complications for patients receiving preoperative chronic oral anticoagulant therapy who undergo colorectal surgery. Surg Endosc. 2013;27(4):1339–45.CrossRefGoogle Scholar
  30. 30.
    Celentano V, Finch D, Forster L, Robinson JM, Griffith JP. Safety of supervised trainee-performed laparoscopic surgery for inflammatory bowel disease. Int J Color Dis. 2015;30(5):639–44.CrossRefGoogle Scholar
  31. 31.
    Giglio MC, Celentano V, Tarquini R, Luglio G, De Palma GD, Bucci L. Conversion during laparoscopic colorectal resections: a complication or a drawback? A systematic review and meta-analysis of short-term outcomes. Int J Colorectal Dis. 2015;30(11):1445–55.CrossRefGoogle Scholar
  32. 32.
    Anderson CD, Bowman LJ, Chapman WC. Topical use of recombinant human thrombin for operative hemostasis. Expert Opin Biol Ther. 2009;9(1):133–7.CrossRefGoogle Scholar
  33. 33.
    Spotnitz WD, Burks S. Hemostats, sealants, and adhesives III: a new update as well as cost and regulatory considerations for components of the surgical toolbox. Transfusion. 2012;52(10):2243–55.CrossRefGoogle Scholar
  34. 34.
    Zama N, Fazio VW, Jagelman DG, et al. Efficacy of pelvic packing in maintaining hemostasis after rectal excision for cancer. Dis Colon Rectum. 1988;31:923–8.CrossRefGoogle Scholar
  35. 35.
    McCourtney JS, Hussain N, Mackenzie I. Balloon tamponade for control of massive presacral haemorrhage. Br J Surg. 1996;83:222.CrossRefGoogle Scholar
  36. 36.
    Timmons MC, Kohler MF, Addison WA. Thumbtack use for control of presacral bleeding, with description of an instrument for thumbtack application. Obstet Gynecol. 1991;78:313–5.PubMedGoogle Scholar
  37. 37.
    Harrison JL, Hooks VH, Pearl RK, et al. Muscle fragment welding for control of massive presacral bleeding during rectal mobilization: a review of eight cases. Dis Colon Rectum. 2003;46:1115–7.CrossRefGoogle Scholar
  38. 38.
    Celentano V, Ausobsky JR, Vowden P. Surgical management of presacral bleeding. Ann R Coll Surg Engl. 2014;96(4):261–5.CrossRefGoogle Scholar
  39. 39.
    Golda T, Zerpa C, KreislerE, Trenti L,Biondo S. Incidence and management of anastomotic bleeding after ileocolic anastomosis. Colorectal Disease. 2013;15(10):1301–8.CrossRefGoogle Scholar
  40. 40.
    Asher Hirshberg. Reoperation for Bleeding in Trauma. Archives of Surgery. 1993;128(10):1163.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Colorectal Surgery, Queen Alexandra HospitalPortsmouth Hospitals NHS TrustPortsmouthUK
  2. 2.University of PortsmouthPortsmouthUK

Personalised recommendations